Modern Diagnostic & Research Centre IPO Listing at 10.56% Premium at ₹99.50 Per Share

Wed Jan 07 2026

Modern Diagnostic & Research Centre IPO listing: The Modern Diagnostic & Research Centre IPO was subscribed 376.90 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 193.51 times, and non-institutional investors (NIIs) received 702.08 times. The retail quota of the issue was subscribed to 33.26%. Before delving deeper into the topic, go through the details of the Modern Diagnostic & Research Centre IPO.

Table of Contents

Modern Diagnostic & Research Centre IPO

It is a bookbuilding IPO of ₹36.89 crore, an entirely fresh issue of 0.41 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 7th January 2026. The Modern Diagnostic & Research Centre IPO date is fixed between 31st December 2025 and 2nd January 2026. The face value of Modern Diagnostic & Research Centre shares stands at ₹10 per share, and the IPO Issue price band is set at ₹85 to ₹90 per share

IPO Allotment Date	5th January 2026
IPO Open Date	31st December 2025
IPO Close Date	6th January 2026
Refund Initiation	1st January 2026
Issue Size	40,99,200 shares(agg. up to ₹37 Cr)
Face Value	₹10 per share
Lot Size	1,600 Shares
Issue Price	₹85 to ₹90 per share
Issue Type	Bookbuilding IPO
Listing At	BSE SME
Listing Date	7th January 2026

Modern Diagnostic & Research Centre IPO Listing

On the BSE & SME platforms, Modern Diagnostic & Research Centre shares are listed at ₹99.50 per share, reflecting a 10.56% premium to the issue price of ₹90.00 per share.

About the Modern Diagnostic & Research Centre IPO

Modern Diagnostic & Research Centre was established in 2016. Modern Diagnostic & Modern Diagnostic & Research Centre was established in 1985. Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services. The company provides reliable diagnostic tests, home specimen collection, online reports, and customised test packages for institutional customers and patients, tailored to their specific needs. The company operates 21 centres (18 labs, three diagnostic centres) across eight states, offering diagnostic services such as ultrasound, CT, MRI, X-ray, ECG, PFT, and specialised labs for heart and neuro care. The company has been providing services such as Pathology, Radiology and Home sample collection.

Modern Diagnostic & Research Centre Limited Financials

The company’s financial analysis is essential before applying for Modern Diagnostic & Research Centre Limited’s IPO. Refer to the table to learn about Vidya Wires Limited’s financial information.

Year Ended	30th June 2025 (in cr.)	31st March 2025 (in cr.)	31st March 2024	31st March 2023
Assets	77.86	64.57	49.49	36.54
Revenue	22.67	78.80	68.67	56.61
Profit After Tax	3.00	8.97	5.79	-5.73
EBITDA	5.86	17.96	11.05	-0.99
Net Worth	23.72	20.73	11.76	5.96
Reserves and Surplus	12.72	9.73	10.76	4.96
Total Borrowings	30.38	22.09	20.46	15.31

Explanation

Modern Diagnostic & Research Centre Limited’s revenue increased by 15% from ₹68.67 crores in March 2024 to ₹78.80 crores in March 2025. Moreover, the company’s PAT increased by 55% from ₹5.79 crores in March 2024 to ₹8.97 crores in March 2025.